Hypercholesterolemia: all 1,267 studies

Page 7 of 13. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.

• A Study of PCSK9 Inhibitor AK102 in Patients With HypercholesterolemiaCompletedNCT04358432Phase 2
• Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 InhibitorsCompletedNCT04319081
• Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin SecretionTerminatedNCT04314167Not applicable
• Effect of Atorvastatin on Carotid Intima Media ThicknessStatus unknownNCT04306627Phase 4
• K-924 Phase III Long Term StudyCompletedNCT04289662Phase 3
• K-924 Phase III Confirmatory StudyCompletedNCT04289649Phase 3
• Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial HypercholesterolemiaCompletedNCT04289285Phase 3
• Long-term Consumption of Resistant Starch Type-4 (RS4)WithdrawnNCT04277741Not applicable
• The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan TreatmentStatus unknownNCT04270344
• Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
• Kefir Cholesterol Lowering Pilot StudyCompletedNCT04247139Not applicable
• A Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health SubjectsCompletedNCT04197817Phase 1
• Safety and Efficacy of IBI306 in HeFH PatientsCompletedNCT04179669Phase 3
• A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)CompletedNCT04173793Phase 2
• A Long-term Study of AK102 in Patients With HypercholesterolemiaCompletedNCT04173403Phase 2
• A Study of PCSK9 Inhibitor AK102 in Healthy SubjectsCompletedNCT04169386Phase 1
• Supplementation of Oil Palm Phenolics to Healthy ParticipantsStatus unknownNCT04164446Phase 1
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/AmlodipineCompletedNCT04158076Phase 3
• Arts & Health Education to Improve Health, Resilience, and Well-BeingTerminatedNCT04154579Not applicable
• Effect of Dietary Intervention on LDL-C and Lipoprotein Subclasses Distribution in Patients With HypercholesterolemiaCompletedNCT04148976Not applicable
• A Pilot Study to Explore the Role of Gut Flora in Elevated CholesterolWithdrawnNCT04148339
• Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) PatientsCompletedNCT04148001
• Plant Sterol INtervention for Cancer Prevention (PINC)Status unknownNCT04147767Not applicable
• The Effect of Viscous Dietary Fibers on LDL-cholesterolStatus unknownNCT04133805
• Genetic Causes of Familial HypercholesterolemiaActive, not recruitingNCT04101149
• A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501Active, not recruitingNCT04080050
• A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol LevelsCompletedNCT04058834Phase 1
• A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial HypercholesterolemiaCompletedNCT04031742Phase 2/3
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
• Effect of Probiotics on Lipid ManagementStatus unknownNCT03952169Not applicable
• Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic PatientsCompletedNCT03949374Phase 4
• Ezetimibe-Rosuvastatin Evaluation StudyStatus unknownNCT03947866
• Improving Identification of Familial Hypercholesterolaemia in Primary Care (FAMCAT)Status unknownNCT03934320Not applicable
• A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFHCompletedNCT03933293Phase 2
• Translation of Pritikin Program to the CommunityCompletedNCT03929198Not applicable
• Sí Texas Hope Family Health CenterCompletedNCT03916016Not applicable
• Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent PpciStatus unknownNCT03900169
• Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)CompletedNCT03885921Phase 3
• Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)CompletedNCT03884452Phase 3
• A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)CompletedNCT03882996Phase 3
• A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)CompletedNCT03882905Phase 3
• Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)CompletedNCT03882892Phase 3
• Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico BorderCompletedNCT03881657Not applicable
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and TelmisartanCompletedNCT03872232Phase 3
• Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)CompletedNCT03867318Phase 3
• An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)CompletedNCT03867110Phase 3
• The Effect of Childhood Dyslipidemia on Endothelial and Renal FunctionCompletedNCT03856476
• Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol and Other Cardiovascular Disease Risk Biomarkers in Adults With Elevated LDL CholesterolCompletedNCT03830970Not applicable
• Clinical Trial to Demonstrate the Efficacy of a Dietary Supplement in Decreasing Cardiovascular RiskCompletedNCT03828006Not applicable
• Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With HypercholesterolemiaCompletedNCT03815812Phase 2
• Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALICompletedNCT03795038Not applicable
• Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant HypercholesterolemiaWithdrawnNCT03756779Not applicable
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCICompletedNCT03718286Phase 2
• Return of Actionable Variants Empirical StudyCompletedNCT03640234
• The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy SubjectsCompletedNCT03634436Phase 1
• The Dual Impact of Homocysteine and Cholesterol on Cognitive FunctionsCompletedNCT03631238
• Lipid-lowering Therapy IndividualizationCompletedNCT03604471Phase 4
• Genetic Causes of Hypercholesterolaemia in the Emirati PopulationStatus unknownNCT03597958
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.CompletedNCT03593785Phase 1
• Safety and Efficacy of Propionate for Reduction of LDL CholesterolCompletedNCT03590496Not applicable
• Low Versus High-glycemic Index Post-exercise Diets for Improving Metabolism and Body CompositionCompletedNCT03587051Not applicable
• Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary HypercholesterolemiaCompletedNCT03571087Phase 3
• Effects of Soy Protein on Cholesterol Levels in Children Affected With Familial HypercholesterolemiaCompletedNCT03563547Not applicable
• Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial LipemiaTerminatedNCT03559309Phase 4
• Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate HyperlipidemiaCompletedNCT03550287Phase 4
• Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003CompletedNCT03545438Phase 1
• Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease PopulationStatus unknownNCT03543774Phase 4
• Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic SyndromeCompletedNCT03542240Not applicable
• The Efficacy of Cholesterol-lowering Probiotic Lactobacillus Plantarum LPLDL® in Hypercholesterolemic Adults.CompletedNCT03540108Not applicable
• Habitual Diet and Avocado TrialCompletedNCT03528031Not applicable
• Prevalence of Familial Hypercholesterolaemia (FH) in Italian Patients With Coronary Artery DiseaseCompletedNCT03520140
• Efficacy and Safety of a Generic Rosuvastatin in a Real-world SettingCompletedNCT03516955
• Study of Coronary Calcification in Subjects With Autosomal Dominant Familial Hypercholesterolemia HeterozygousCompletedNCT03501875Not applicable
• Alirocumab in Patients on a Stable Dialysis RegimenStatus unknownNCT03480568Phase 3
• Effect of Indian Gooseberry Extract (AMX160) in HypercholesterolemiaStatus unknownNCT03479983Not applicable
• NUtraceutical TReatment for hYpercholesterolemia in HIV-infected PatientsCompletedNCT03470376Phase 4
• Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal MarkersStatus unknownNCT03469518Not applicable
• Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary HypercholesterolemiaStatus unknownNCT03464682Phase 3
• Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)WithdrawnNCT03455777Phase 2
• The Effect of Oats Containing 1.4g Beta Glucan on Fecal Bacterial Population(s) and Plasma Cholesterol in Healthy Adults With Elevated Cholesterol LevelsCompletedNCT03450395Not applicable
• Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and HypercholesterolemiaCompletedNCT03446261Phase 4
• Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart DiseasesCompletedNCT03433196Phase 3
• Evolocumab Versus LDL Apheresis in Patients With HypercholesterolemiaCompletedNCT03429998Phase 3
• Detection and Treatment of Somatic Disease in Patients With Severe Mental DiseaseStatus unknownNCT03428308Not applicable
• The ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management StudyStatus unknownNCT03428061
• A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol LevelCompletedNCT03427710Phase 1
• LDL-cholesterol Lowering Effect of a New Dietary SupplementCompletedNCT03425630Not applicable
• Efficacy and Safety Study of HS-25 in Chinese Adults With Primary HypercholesterolemiaCompletedNCT03413462Phase 3
• a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial HypercholesterolemiaStatus unknownNCT03398954
• Electronic Medical Records and Genomics (eMERGE) Phase IIICompletedNCT03394859
• Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health OutcomesCompletedNCT03392350Not applicable
• Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance StudyTerminatedNCT03379558
• Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects.CompletedNCT03366688Phase 1
• The Effect of Psyllium Fibre on LDL-C, Non-HDL-C, and Apolioprotein-B: A Systematic Review and Meta-analysisStatus unknownNCT03346733
• Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With StatinsStatus unknownNCT03310671
• The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaCompletedNCT03288038Phase 3
• Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol EsterCompletedNCT03284918Not applicable
• IN-TANDEM Familial Hypercholesterolemia Pilot StudyCompletedNCT03253432
• Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemiaCompletedNCT03234127Not applicable
• A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and HypercholesterolemiaCompletedNCT03217409Phase 4

← Hypercholesterolemia overview